Assertio (ASRT) News Today $0.71 +0.03 (+3.92%) As of 11:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASRT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period HC Wainwright Reaffirms "Buy" Rating for Assertio (NASDAQ:ASRT)HC Wainwright reiterated a "buy" rating and set a $3.50 target price on shares of Assertio in a research note on Monday.May 21 at 8:15 AM | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Assertio (NASDAQ:ASRT)May 20 at 1:37 AM | americanbankingnews.comAssertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025May 19 at 4:10 PM | globenewswire.comAssertio (NASDAQ:ASRT) Downgraded to Hold Rating by StockNews.comStockNews.com lowered Assertio from a "buy" rating to a "hold" rating in a research note on Monday.May 15, 2025 | marketbeat.comAssertio (NASDAQ:ASRT) Announces Quarterly Earnings Results, Misses Estimates By $0.11 EPSAssertio (NASDAQ:ASRT - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.11). Assertio had a positive return on equity of 3.79% and a negative net margin of 54.46%.May 14, 2025 | marketbeat.comAssertio outlines 2025 transformation phase with $108M-$123M revenue guidance while advancing Rolvedon and Sympazan growthMay 13, 2025 | seekingalpha.comAssertio Holdings, Inc. (NASDAQ:ASRT) Q1 2025 Earnings Call TranscriptMay 13, 2025 | insidermonkey.comAssertio Holdings, Inc.: Assertio Reports First Quarter 2025 Financial ResultsMay 13, 2025 | finanznachrichten.deAssertio Holdings Inc (ASRT) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...May 13, 2025 | finance.yahoo.comAssertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comAssertio Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comAssertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025May 5, 2025 | globenewswire.comNantahala Capital Management LLC Trims Position in Assertio Holdings, Inc. (NASDAQ:ASRT)Nantahala Capital Management LLC decreased its position in shares of Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) by 8.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 8,148,336 shares of the company's stock after selling 800,000 shares during tApril 30, 2025 | marketbeat.comAssertio (ASRT) Expected to Announce Earnings on MondayAssertio (NASDAQ:ASRT) will be releasing its Q1 2025 earnings before the market opens on Monday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-5-assertio-holdings-inc-stock/)April 30, 2025 | marketbeat.comStockNews.com Upgrades Assertio (NASDAQ:ASRT) to BuyStockNews.com upgraded shares of Assertio from a "hold" rating to a "buy" rating in a research report on Monday.April 16, 2025 | marketbeat.comAssertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025March 20, 2025 | globenewswire.comAssertio (NASDAQ:ASRT) Price Target Lowered to $3.50 at HC WainwrightHC Wainwright cut their price objective on shares of Assertio from $4.00 to $3.50 and set a "buy" rating on the stock in a research report on Wednesday.March 20, 2025 | marketbeat.comAssertio Holdings price target lowered to $3.50 from $4 at H.C. WainwrightMarch 19, 2025 | markets.businessinsider.comAssertio (NASDAQ:ASRT) Lowered to "Hold" Rating by StockNews.comStockNews.com cut Assertio from a "buy" rating to a "hold" rating in a research note on Monday.March 18, 2025 | marketbeat.comSidoti Csr Issues Pessimistic Forecast for Assertio EarningsAssertio Holdings, Inc. (NASDAQ:ASRT - Free Report) - Equities researchers at Sidoti Csr dropped their Q3 2025 EPS estimates for shares of Assertio in a note issued to investors on Thursday, March 13th. Sidoti Csr analyst J. Sidoti now expects that the company will post earnings of $0.00 per sharMarch 17, 2025 | marketbeat.comAssertio price target lowered to $1.75 from $2.15 at Alliance GlobalMarch 14, 2025 | markets.businessinsider.comAssertio Holdings, Inc. (NASDAQ:ASRT) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comAssertio Therapeutics (ASRT) Gets a Buy from Lake StreetMarch 13, 2025 | markets.businessinsider.comAssertio (NASDAQ:ASRT) Releases Earnings Results, Misses Estimates By $0.06 EPSAssertio (NASDAQ:ASRT - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.06). Assertio had a positive return on equity of 3.79% and a negative net margin of 54.46%.March 13, 2025 | marketbeat.comAssertio Holdings, Inc.: Assertio Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 13, 2025 | finanznachrichten.deAssertio (ASRT) Reports Q4 Loss, Tops Revenue EstimatesMarch 12, 2025 | msn.comAssertio Holdings, Inc. (ASRT) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comAssertio Holdings, Inc. Reports Q4 2024 Financial Results with $29.6 Million in Net Product Sales and $11.5 Million in Cash Flow from OperationsMarch 12, 2025 | quiverquant.comAssertio Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 12, 2025 | globenewswire.comAssertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025March 5, 2025 | globenewswire.comAssertio (ASRT) to Release Quarterly Earnings on MondayAssertio (NASDAQ:ASRT) will be releasing earnings before the market opens on Monday, March 10, Financial Modeling Prep reports.March 3, 2025 | marketbeat.comAssertio Holdings, Inc. (NASDAQ:ASRT) Short Interest UpdateAssertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 5,730,000 shares, a drop of 5.1% from the January 15th total of 6,040,000 shares. Based on an average daily volume of 754,900 shares, the days-to-cover ratio is presently 7.6 days.February 18, 2025 | marketbeat.comINVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with CounselFebruary 12, 2025 | globenewswire.comInvestors in Assertio Holdings (NASDAQ:ASRT) have unfortunately lost 87% over the last five yearsFebruary 2, 2025 | uk.finance.yahoo.comAssertio Holdings, Inc. (NASDAQ:ASRT) Sees Significant Decrease in Short InterestAssertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 5,910,000 shares, a decline of 6.5% from the December 31st total of 6,320,000 shares. Based on an average trading volume of 764,400 shares, the short-interest ratio is presently 7.7 days.February 1, 2025 | marketbeat.comAssertio Holdings faces Nasdaq delisting over share price ruleJanuary 29, 2025 | msn.comAssertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 6.5% in DecemberAssertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 5,910,000 shares, a drop of 6.5% from the December 15th total of 6,320,000 shares. Based on an average trading volume of 764,400 shares, the short-interest ratio is currently 7.7 days.January 18, 2025 | marketbeat.comSidoti Remains a Hold on Assertio Therapeutics (ASRT)January 16, 2025 | markets.businessinsider.comAssertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)January 3, 2025 | gurufocus.comAssertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)January 3, 2025 | globenewswire.comAssertio Therapeutics Announces Leadership Changes and Board AdditionDecember 18, 2024 | markets.businessinsider.comPositive Clinical Results and Market Potential Drive Buy Rating for Assertio TherapeuticsDecember 17, 2024 | markets.businessinsider.comAssertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of DirectorsDecember 17, 2024 | globenewswire.comAssertio's (ASRT) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $4.00 target price on shares of Assertio in a research report on Monday.December 16, 2024 | marketbeat.comAssertio Holdings, Inc.: Assertio Announces Results of Rolvedon (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyDecember 13, 2024 | finanznachrichten.deAssertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyDecember 13, 2024 | globenewswire.comAssertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCODecember 12, 2024 | markets.businessinsider.comLake Street Sticks to Its Buy Rating for Assertio Therapeutics (ASRT)November 28, 2024 | markets.businessinsider.comHC Wainwright Analysts Boost Earnings Estimates for AssertioAssertio Holdings, Inc. (NASDAQ:ASRT - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings estimates for Assertio in a research report issued to clients and investors on Monday, November 25th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earNovember 28, 2024 | marketbeat.comAssertio Therapeutics: Strong Buy Rating Backed by Robust Margins and Strategic Revenue GrowthNovember 26, 2024 | markets.businessinsider.com Get Assertio News Delivered to You Automatically Sign up to receive the latest news and ratings for ASRT and its competitors with MarketBeat's FREE daily newsletter. Email Address ASRT Media Mentions By Week ASRT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASRT News Sentiment▼0.110.65▲Average Medical News Sentiment ASRT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASRT Articles This Week▼52▲ASRT Articles Average Week Get Assertio News Delivered to You Automatically Sign up to receive the latest news and ratings for ASRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cartesian Therapeutics News Today 2seventy bio News Today Inozyme Pharma News Today Monte Rosa Therapeutics News Today Palvella Therapeutics News Today Lifecore Biomedical News Today Tango Therapeutics News Today Gossamer Bio News Today Corvus Pharmaceuticals News Today Aquestive Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ASRT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assertio Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assertio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASRT Stock Free ASRT Stock Alerts